Explore the challenges in drug discovery amid political shifts and market changes affecting the pharmaceutical industry.

Explore the potential of CTX-09 against MDR bacteria and its effectiveness in addressing antibiotic resistance challenges.

A new study at Science Tokyo has developed patient-derived organoids to better understand and combat resistance in oesophageal squamous cell carcinoma (ESCC). “Unlike artificial models that are ...

Genomics laid the foundation for precision medicine, but on its own, it offers only part of the picture. This article explores how integrated multiomics can provide the deeper biological context ...

Researchers at the University of Alabama have identified reelin, a glycoprotein known for its role in brain development, as a key regulator of neurons in the brain’s reward centre, potentially making ...

What if you could actually see where a drug travels in the body down to the cellular level. Find out how mass spectrometry imaging (MSI) is making that possible – reshaping drug development from the ...

Stanford scientists have successfully grown heart and liver organoids that include functioning blood vessels. This breakthrough overcomes a major size and maturity barrier, which could advance disease ...

Discover how Domain Therapeutics is using its deep knowledge of GPCR biology to create novel therapeutics with the potential to combat inflammatory diseases such as atopic dermatitis, IBD and ...

Lab scientists and data scientists often speak different languages and that miscommunication can slow down important research. In this interview, Ian Kerman shares how his team is working to break ...

Understand the challenges and impacts of the 3Rs on animal welfare in research with Dr. Liz Nunamaker's expert interview.

Scientists have developed a simple- 3D mouse tissue model to study how the nose regenerates smell-sensing neurons. The goal ...